Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors
- PMID: 322257
- DOI: 10.1111/j.1365-3083.1977.tb00327.x
Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors
Abstract
The activity of leukocyte migration inhibitory factor (LIF) obtained from Sephadex-G-100-chromatographed supernatants of concanavalin-A-stimulated human lymphocytes was suppressed by two synthetic serine esterase and serine protease inhibitors (di-isopropylfluorophosphate (DFP) and phenylmethylfulfonyl fluoride (PMSF)). LIF activity was also reduced by the naturally occurring protease inhibitors soybean trypsin inhibitor and aprotinin. The observed effect of DFP and PMSF was irreversible, since elimination of the inhibitors by dialysis did not restore LIF activity. The effect of PMSF was dose-, time-, and temperature-dependent, and hydrolytic products of PMSF as well as sodium fluoride were inactive in blocking LIF. These results suggest that LIF may act as a serine esterase or a serine protease, or both of these, and that this putative enzyme is present in an activated form in supernatants from mitogen-stimulated mononuclear cells.
Similar articles
-
Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.Scand J Immunol. 1977;6(1-2):126-31. Scand J Immunol. 1977. PMID: 322258
-
Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.Scand J Immunol. 1977;6(1-2):133-40. doi: 10.1111/j.1365-3083.1977.tb00328.x. Scand J Immunol. 1977. PMID: 322260
-
Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.Scand J Immunol. 1977;6(12):1357-61. Scand J Immunol. 1977. PMID: 203999
-
Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).Acta Pathol Microbiol Scand C. 1976 Dec;84C(6):471-6. doi: 10.1111/j.1699-0463.1976.tb00057.x. Acta Pathol Microbiol Scand C. 1976. PMID: 11637
-
Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.Scand J Immunol. 1977;6(10):1055-62. Scand J Immunol. 1977. PMID: 335493
Cited by
-
Production of leucocyte migration inhibitory factor (LIF) in infectious mononucleosis. Spontaneous release and lack of response to concanavalin A.Clin Exp Immunol. 1978 Jan;31(1):66-71. Clin Exp Immunol. 1978. PMID: 639351 Free PMC article.
-
Potentiation of neutrophil aggregation by human leukocyte inhibitory factor.Inflammation. 1988 Jun;12(3):203-11. doi: 10.1007/BF00920072. Inflammation. 1988. PMID: 2843462
-
Physiological studies with human leukocyte inhibitory factor.Surv Immunol Res. 1985;4(3):230-7. doi: 10.1007/BF02918676. Surv Immunol Res. 1985. PMID: 3003858 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources